NEO vs LIFE
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NEO · NeoGenomics$16.84 ▲ 2.12%
LIFE · Ethos Technologies$33.51 ▲ 2.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NEO +35.8%
- LIFE +98.9%
Head to head
| Metric | NEO | LIFE |
|---|---|---|
| Price | $16.84 | $33.51 |
| Change today | ▲ 2.12% | ▲ 2.73% |
| Market cap | $2.18B | $2.18B |
| Return, 3 months | +1.3% | +3.3% |
| Return, year to date | +43.2% | – |
| Return, 1 year | +67.1% | – |
| P/E (TTM) | – | – |
| P/B | 2.7 | 4.3 |
| P/E percentile vs own 5y | 4th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +11.4% | +113.4% |
| Net profit growth (YoY) | +72.2% | +5.8% |
| Gross margin | 44.8% | 98.1% |
| Operating margin | -6.2% | -17.7% |
| Net margin | -4.1% | -18.1% |
| Return on equity | -3.9% | -22.4% |
| Analyst target vs. price | +46.7% | +11.9% |
| Analyst buy share | 78% | 89% |
| RSI (14) | 48 | 35 |
| 30-day volatility | 60.6% | 68.3% |
| Max drawdown, 1 year | -45.6% | -50.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NEO is the largest of the group by market value.
- LIFE is growing revenue fastest.
- NEO keeps the most profit per dollar of sales.
- NEO has been the calmest stock over the last 30 days.